ABBOTT LABORATORIES — Director's Dealing 2021

Nov 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-11-15

Reporting Person: Ahlberg Gregory A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-15	Common shares without par value	M	6000	$48.98	Acquired	19825	Direct
2021-11-15	Common shares without par value	S	3905	$130	Disposed	15920	Direct
2021-11-15	Common shares without par value	M	30935	$59.94	Acquired	46855	Direct
2021-11-15	Common shares without par value	S	21568	$130	Disposed	25287	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Option (right to buy)	$48.98	M	6000	Disposed	2027-08-13	Common Shares (6000)	Direct
2021-11-15	Option (right to buy)	$59.94	M	30935	Disposed	2028-02-15	Common Shares (30935)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10746	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 15, 2021.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.